H.R. 6833 - 117th Congress (2021-2022) - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023

Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2023.

The bill caps cost-sharing under the Medicare prescription drug benefit for insulin products at (1) $35 in 2023 regardless of whether a beneficiary has reached the annual out-of-pocket spending threshold, and (2) $35 beginning in 2024 for those who have not yet reached this threshold.

Currently, the Centers for Medicare & Medicaid Services is testing a voluntary model under the Medicare prescription drug benefit (the Part D Senior Savings Model) in which the copayment for a month's supply of insulin is capped at $35 through participating plans. The model is set to expire on December 31, 2025.

Text (5)

Enrolled Bill

Engrossed Amendment Senate

September 29, 2022

Placed on Calendar Senate

May 25, 2022

Engrossed in House

March 31, 2022

Introduced in House

February 25, 2022

Amendments (13)

Show All Amendments

Displaying only amendments with a detailed public record (5)

Sep 28, 2022

Submitted in Senate

Sponsorship

Senate Amendment 6032 to Senate Amendment 6031

To modify the effective date.

Submitted

Sep 28, 2022

Submitted in Senate

Sponsorship

Senate Amendment 6031

To add an effective date.

Submitted

Amendments

Sep 28, 2022

Submitted in Senate

Sponsorship

Senate Amendment 6030 to Senate Amendment 5745

To add an effective date.

Submitted

Sep 28, 2022

Submitted in Senate

Sponsorship

Senate Amendment 5765 to Senate Amendment 5745

To amend chapter 2 of title 1, United States Code, to create requirements for calling an Article V Convention, and for other purposes.

Submitted

Sep 29, 2022

Agreed to in Senate

Sponsorship

Senate Amendment 5745

In the nature of a substitute.

Agreed To

Amendments

Actions (45)

Show Only Major Actions

09/30/2022

Became Public Law No: 117-180.

09/30/2022

Signed by President.

09/30/2022

Presented to President.

09/30/2022

Motion to reconsider laid on the table Agreed to without objection.

09/30/2022

On motion that the House agree to the Senate amendment Agreed to by the Yeas and Nays: 230 - 201 (Roll no. 476).

09/30/2022

Resolving differences -- House actions: On motion that the House agree to the Senate amendment Agreed to by the Yeas and Nays: 230 - 201 (Roll no. 476).

09/30/2022

POSTPONED PROCEEDINGS - At the conclusion of debate on the motion to agree to the Senate amendment to H.R. 6833, the Chair put the question on agreeing to the motion and by voice vote, announced that the ayes had prevailed. Mrs. Granger demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.

09/30/2022

The previous question was ordered pursuant to the rule.

09/30/2022

DEBATE - Pursuant to H. Res. 1404, the House proceeded with one hour of debate on the motion to agree to the Senate amendment to H.R. 6833.

09/30/2022

Ms. DeLauro moved that the House agree to the Senate amendment. (consideration: CR H8330-8350, H8354-8355)

09/29/2022

Message on Senate action sent to the House.

09/29/2022

Passed Senate under the order of 9/29/2022, having achieved 60 votes in the affirmative with an amendment by Yea-Nay Vote. 72 - 25. Record Vote Number: 351.

09/29/2022

Passed/agreed to in Senate: Passed Senate under the order of 9/29/2022, having achieved 60 votes in the affirmative with an amendment by Yea-Nay Vote. 72 - 25. Record Vote Number: 351.

09/29/2022

Cloture motion on the measure withdrawn by unanimous consent in Senate.

09/29/2022

Motion by Senator Schumer to commit to Senate Committee on Appropriations with instructions to report back forthwith with the following amendment (SA 6031) withdrawn in Senate.

09/29/2022

Considered by Senate.

09/28/2022

Cloture motion on the measure presented in Senate. (CR S5148)

09/28/2022

Motion by Senator Schumer to commit to Senate Committee on Appropriations with instructions to report back forthwith with the following amendment (SA 6031) made in Senate. (CR S5148)

09/28/2022

Measure laid before Senate by motion.

09/28/2022

Motion to proceed to consideration of measure agreed to in Senate by Voice Vote.

09/28/2022

Motion to proceed to measure considered in Senate. (CR S5115)

09/27/2022

Cloture on the motion to proceed to the measure invoked in Senate by Yea-Nay Vote. 72 - 23. Record Vote Number: 349. (CR S5045-5046)

09/27/2022

Motion to proceed to measure considered in Senate.

09/22/2022

Cloture motion on the motion to proceed to the measure presented in Senate. (CR S4955)

09/22/2022

Motion to proceed to consideration of measure made in Senate. (CR S4955)

05/25/2022

Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 389.

05/24/2022

Read the first time. Placed on Senate Legislative Calendar under Read the First Time.

04/04/2022

Received in the Senate.

03/31/2022

Motion to reconsider laid on the table Agreed to without objection.

03/31/2022

On passage Passed by the Yeas and Nays: 232 - 193 (Roll no. 102). (text: CR H4033-4034)

03/31/2022

Passed/agreed to in House: On passage Passed by the Yeas and Nays: 232 - 193 (Roll no. 102).(text: CR H4033-4034)

03/31/2022

On motion to recommit Failed by the Yeas and Nays: 197 - 225 (Roll no. 101).

03/31/2022

Considered as unfinished business. (consideration: CR H4053-4055)

03/31/2022

POSTPONED PROCEEDINGS - At the conclusion of the debate on H.R. 6833, the Chair put the question on the motion to recommit and by voice vote announced the noes had prevailed. Mr. Bucshon demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.

03/31/2022

The previous question on the motion to recommit was ordered pursuant to clause 2(b) of rule XIX.

03/31/2022

Mr. Bucshon moved to recommit to the Committee on Energy and Commerce. (text: CR H4046)

03/31/2022

The previous question was ordered pursuant to the rule.

03/31/2022

DEBATE - The House proceeded with one hour of debate on H.R. 6833.

03/31/2022

Rule provides for consideration of H.R. 3617 and H.R. 6833. The resolutions provides for one hour of general debate on H.R. 3617, under a structured rule. The resolution provides for one hour of general debate on H.R. 6833, under a closed rule. The rule provides that House Resolution 188, agreed to March 8, 2021, is amended by striking April 1, 2022 each place it appears and inserting April 29, 2022.

03/31/2022

Considered under the provisions of rule H. Res. 1017. (consideration: CR H4033-4046)

03/31/2022

Rule H. Res. 1017 passed House.

03/31/2022

Rules Committee Resolution H. Res. 1017 Reported to House. Rule provides for consideration of H.R. 3617 and H.R. 6833. The resolutions provides for one hour of general debate on H.R. 3617, under a structured rule. The resolution provides for one hour of general debate on H.R. 6833, under a closed rule. The rule provides that House Resolution 188, agreed to March 8, 2021, is amended by striking April 1, 2022 each place it appears and inserting April 29, 2022.

02/28/2022

Referred to the Subcommittee on Health.

02/25/2022

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

02/25/2022

Introduced in House

Public Record

Record Updated

Sep 5, 2023 5:28:33 PM